‌

US Patent 10787520 Multimeric bispecific binding molecules specific for CD20 and CD3

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

IGM Biosciences

Current Assignee

IGM Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

September 29, 2020

Patent Application Number

15554301

Date Filed

March 4, 2016

Patent Citations

US Patent 10604559 Multi-valent hepatitis B virus antigen binding molecules and uses thereof

US Patent 10351631 Constant chain modified bispecific, penta- and hexavalent Ig-M antibodies

0

US Patent 10400038 Modified J-chain

0

US Patent 10618978 Binding molecules with modified J-chain

Patent Citations Received

US Patent 11578131 Polynucleotides encoding death domain-containing receptor-5 (DR5) binding molecules

US Patent 11535664 Multi-valent hepatitis B virus antigen binding molecules and uses thereof

US Patent 11542342 Binding molecules with modified J-chain

0

US Patent 11555075 Modified J-chain

US Patent 10899835 IgM Fc and J-chain mutations that affect IgM serum half-life

0

US Patent 10954302 Anti-PD-L1 antibodies

US Patent 10975147 Modified J-chain

Patent Primary Examiner

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10787520 Multimeric bispecific binding molecules specific for CD20 and CD3

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.